At least $74,616 was billed for COVID-19-specific services through Medicaid in Algonquin during 2024, as reported by the U.S. Department of Health and Human Services Medicaid Provider Spending database.
Medicaid functions as a state-operated, jointly state- and federally financed public health insurance program. It provides coverage for low-income people, children, seniors and those with disabilities and is a significant sector of American health care.
Variations in Medicaid billings illustrate community-level shifts in how public health care funds are spent—from resources ultimately supplied by taxpayers.
Researchers pinpointed COVID-19–related services and billing based on HCPCS codes flagged as “COVID-19” or “coronavirus” in billing references. As such, these numbers track only services explicitly classified as COVID-related in billing; pandemic-driven care attributed to other medical billing categories is not included here.
In Illinois, Chicago had the state’s highest total for Medicaid COVID-19 service billings in 2024, amounting to $5,867,303 in related claims.
Data identifies Oak Crest Laboratory Services, Inc as the sole Medicaid submitter for COVID-19–linked claims in Algonquin for 2024.
COVID-related Medicaid services represented a distinct portion of spending gains seen during the pandemic-era years in Algonquin.
All other Medicaid claim categories showed a $425,691 rise in total payments from 2021 to 2024, which equates to a 681.7% increase across that span.
Throughout the two years leading up to the pandemic, Algonquin’s annual average Medicaid payments totaled $22,959.
According to the Centers for Medicare & Medicaid Services, the combined spending for state and federal Medicaid approaches $871.7 billion for FY 2023. That makes up close to 18% of total U.S. health expenditures. The total is up from roughly $613.5 billion in 2019, before the COVID-19 outbreak.
This constitutes almost 40% growth over several years, primarily triggered by higher Medicaid enrollment and greater medical service use related to the pandemic period.
Recent federal spending measures from the Trump administration have introduced major plans to shrink federal Medicaid funding and overhaul the system. For instance, the “One Big Beautiful Bill Act,” signed in 2025, is forecast to reduce over $1 trillion in federal Medicaid outlays in the coming decade and implement work requirement provisions along with increased patient cost-sharing. Such moves could decrease coverage or funding for some recipients and shift greater cost burdens to the states—while the program continues serving tens of millions nationally.
| Year | COVID-19–Related Payments | COVID-19 Payments % Change (YoY) | Total Medicaid Payments |
|---|---|---|---|
| 2024 | $74,616 | -48.4% | $562,755 |
| 2023 | $144,570 | 316.8% | $503,717 |
| 2022 | $34,684 | 1,678.3% | $217,935 |
| 2021 | $1,950 | N/A | $64,398 |
| 2020 | $0 | N/A | $34,747 |
| 2019 | $0 | N/A | $25,894 |
| 2018 | $0 | N/A | $20,024 |
| HCPCS Code | Description | Medicaid Payments | Claims |
|---|---|---|---|
| 87811 | Immunoassay | $74,616 | 2,147 |
Note: Includes only explicit COVID-19 HCPCS codes; totals exclude broader pandemic-related service costs.
This article’s information relies on the U.S. Department of Health and Human Services Medicaid Provider Spending database, available here.



